DP092 | MOLECULAR BACKGROUND OF NPM1-MUTATED ACUTE MYELOID LEUKEMIA RECEIVING INTENSIFIED FLUDARABINE-BASED INDUCTION: EXPLORING THE ROLE OF “SECONDARY TYPE” AND HIGH RISK MUTATIONS
Background: NPM1-mutated AML (NPM mut AML) is typically associated with favorable prognosis, but recent studies highlight biological and molecular heterogeneity. FLT3-ITD mutation is used for further risk stratification, while DNMT3A mutations have also been linked to poorer outcomes. The ELN 2022...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , , , , , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Ferrata Storti Foundation
2025-09-01
|
| Cyfres: | Haematologica |
| Mynediad Ar-lein: | https://haematologica.org/article/view/12556 |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
